Clinical Trial Update: RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

Clinical trials update for RBM-007 in age-related macular degeneration (Phase 1/2) completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• RBM-007

Snippet

Sponsor: Ribomic USA Inc | Conditions: Age-related Macular Degeneration | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-01-05